Back to Agenda
Session 1205: PROJECT MANAGEMENT IN DRUG DEVELOPMENT
Session Chair(s)
Yuan Li
Director, Project Management
MSD R&D (China) Co., Ltd., China
Speaker(s)
Overview of Project Management in Drug Development
Timothy M. Phelan, PhD
Merck & Co., Inc., United States
Executive Director
Value Added Project Leadership in New Drug Development, Opportunity and Challenge
Maxwell Kirkby
IRESSA , AstraZeneca, China
Global Product Vice President
Clara Gu
Bayer, China
TA Head Medical Affairs
Michael Jiang
Lilly Suzhou pharmaceutical Co., Ltd., China
COO
Kumar Penmetsa
BristolMyers Squibb, China
Senior Director
Have an account?